Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies
Go back to Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.94 | 52 Week High | $63.73 | |||
| Open | $20.94 | 52 Week Low | $8.00 | |||
| Day High | $20.94 | P/E | N/A | |||
| Day Low | $20.94 | EPS | $-5.69 | |||
| Volume | 479 | |||||
